16042-93-6 Usage
Uses
Used in Pharmaceutical Manufacturing:
2-METHYL-2-PIPERIDINOPROPANAL is used as an intermediate in the synthesis of various pharmaceutical compounds for its ability to contribute to the formation of complex organic molecules.
Used in Organic Synthesis:
2-METHYL-2-PIPERIDINOPROPANAL is used as a building block in organic synthesis for creating a wide range of chemical products due to its reactive aldehyde group and the presence of a piperidine ring.
Used in Medical Applications:
2-METHYL-2-PIPERIDINOPROPANAL is used as an analgesic for its potential pain-relieving properties, offering an alternative for managing pain in various conditions.
Used in Enzyme Inhibition:
2-METHYL-2-PIPERIDINOPROPANAL is used as an inhibitor of certain enzymes, playing a role in the regulation of biological processes and potentially contributing to the treatment of specific diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 16042-93-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,0,4 and 2 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 16042-93:
(7*1)+(6*6)+(5*0)+(4*4)+(3*2)+(2*9)+(1*3)=86
86 % 10 = 6
So 16042-93-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H17NO/c1-9(2,8-11)10-6-4-3-5-7-10/h8H,3-7H2,1-2H3
16042-93-6Relevant academic research and scientific papers
IMMUNOPROTEASOME INHIBITORS
-
Paragraph 0214, (2018/08/20)
Provided herein are compounds, such as a compound of Formula (I), as described herein, or a pharmaceutically acceptable salt thereof, that are immunoproteasome (such as LMP2 and LMP7) inhibitors. The compounds described herein can be useful for the treatment of diseases treatable by inhibition of immunoproteasomes. Also provided herein are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
The Rabe amination after a century: Direct addition of N-heterocycles to carbonyl compounds
Scarpino Schietroma, Daniele M.,Monaco, Mattia R.,Bucalossi, Valerio,Walter, Philipp E.,Gentili, Patrizia,Bella, Marco
supporting information; experimental part, p. 4692 - 4695 (2012/08/08)
A catalytic version of the Rabe electrophilic amination is presented. This kind of reaction was originally employed in 1918 in a key step for the conversion of quinotoxine to quinine. Ketones and α-substituted aldehydes give the corresponding α-aminated carbonyl compounds in moderate yield. α,α-Unsubstituted aldehydes give rise to amino ketones via a novel rearrangement.
